Learn how to adapt business strategy during uncertain times such as the COVID-19 pandemic
Author Archives: Fancy Comma, LLC
How I Learned to Love Neuroplasticity — And Why You Should, Too
In this post, Fancy Comma, LLC’s Sheeva Azma talks about what neuroplasticity is and how it helps humans be more adaptable.
Genuinely Simple Ways to Achieve Balance in a Pandemic
Dawn Beauchamp shares how she has been able to achieve balance amidst the chaos of parenting, work, and life during the COVID-19 pandemic.
In the COVID-19 Pandemic, Science Reporting Matters
In this post, Fancy Comma, LLC’s Sheeva Azma reflects on the state of biomedical science journalism in the COVID-19 pandemic.
The Simplified Guide to Understanding Statistics in the Social Sciences, Part I: Numbers and Graphs
In Part 1 of this two-part series, Fancy Comma, LLC’s Kelly Tabbutt discusses the simplest ways to understand numbers and graphs when interpreting statistics in the social sciences.
How the Novavax Vaccine for COVID-19, A Protein Subunit Vaccine, Works
In this post, Nidhi Parekh of The Shared Microscope talks about Novavax, a protein subunit vaccine being developed for COVID-19.
How Does China’s CoronaVac Vaccine for COVID-19 Work?
Learn more about CoronaVac, a COVID-19 inactivated vaccine being developed by Sinovac in China, in this post by Nidhi Parekh of The Shared Microscope.
How to Pitch Articles (and Get Published)
Read our quick primer on “pitching” story ideas to the media. Our post will help you write the most effective pitches to get your articles published.
5 Experts Muse about the Future of COVID-19
Is a post-COVID-19 world possible? Will COVID-19 become endemic? Should we have done it all differently? What about a vaccine? What are the major troubles we are facing? Nidhi Parekh of The Shared Microscope examines what the experts have to say on these questions.
What’s It Like to Participate in a Clinical Trial for a COVID-19 Vaccine?
We speak to a participant in the Oxford/AstraZeneca vaccine trials for COVID-19 about what it’s like.